Search research articles
Contact Us
Filters
Showing results (81-90 of 89) with videos related to
Page
of 9
Sort By:
You have reached the last page of results.
This site can display upto 89 results.
British Journal of Pharmacology
|
February 26, 2009
CHF5074, a novel gamma-secretase modulator, attenuates brain beta-amyloid pathology and learning deficit in a mouse model of Alzheimer's disease
B P Imbimbo, B Hutter-Paier, G Villetti, et al.
Magyar Sebeszet
|
January 31, 2002
[Simultaneous carotid and coronary operations: experience and results of 11 years (1990-2000)]
Z Szabolcs, L Entz, K Hüttl, et al.
Journal of Neurology, Neurosurgery, and Psychiatry
|
July 1, 2008
Longitudinal multimodal imaging in mild to moderate Alzheimer disease: a pilot study with memantine
R Schmidt, S Ropele, B Pendl, et al.
Neuro-Degenerative Diseases
|
November 7, 2013
Effect of donepezil in Alzheimer disease can be measured by a computerized human analog of the Morris water maze
J Hort, R Andel, I Mokrisova, et al.
Molecular Immunology
|
August 1, 1997
Inhibition of HIV-1 infection in vitro by monoclonal antibodies to the complement receptor type 3 (CR3): an accessory role for CR3 during virus entry?
H Stoiber, I Frank, M Spruth, et al.
Animal : an International Journal of Animal Bioscience
|
August 11, 2022
Review: Bioavailability of trace elements in farm animals: definition and practical considerations for improved assessment of efficacy and safety
D Brugger, B Wagner, W M Windisch, et al.
Neuro-Degenerative Diseases
|
July 17, 2012
Elevated levels of soluble total and hyperphosphorylated tau result in early behavioral deficits and distinct changes in brain pathology in a new tau transgenic mouse model
S Flunkert, M Hierzer, T Löffler, et al.
Journal of Neural Transmission. Supplementum
|
August 29, 2000
Oral Cerebrolysin enhances brain alpha activity and improves cognitive performance in elderly control subjects
X A Alvarez, V R Lombardi, L Corzo, et al.
Drugs of Today (Barcelona, Spain : 1998)
|
July 16, 2003
Pharmacological treatment of Alzheimer disease: from psychotropic drugs and cholinesterase inhibitors to pharmacogenomics
R Cacabelos, A Alvarez, V Lombardi, et al.
Page
of 9
Search research articles
Search
Showing results (81-90 of 89) with videos related to
Sort By:
Page
of 9
You have reached the last page of results.
This site can display upto 89 results.
British Journal of Pharmacology
|
February 26, 2009
CHF5074, a novel gamma-secretase modulator, attenuates brain beta-amyloid pathology and learning deficit in a mouse model of Alzheimer's disease
B P Imbimbo, B Hutter-Paier, G Villetti, et al.
Magyar Sebeszet
|
January 31, 2002
[Simultaneous carotid and coronary operations: experience and results of 11 years (1990-2000)]
Z Szabolcs, L Entz, K Hüttl, et al.
Journal of Neurology, Neurosurgery, and Psychiatry
|
July 1, 2008
Longitudinal multimodal imaging in mild to moderate Alzheimer disease: a pilot study with memantine
R Schmidt, S Ropele, B Pendl, et al.
Neuro-Degenerative Diseases
|
November 7, 2013
Effect of donepezil in Alzheimer disease can be measured by a computerized human analog of the Morris water maze
J Hort, R Andel, I Mokrisova, et al.
Molecular Immunology
|
August 1, 1997
Inhibition of HIV-1 infection in vitro by monoclonal antibodies to the complement receptor type 3 (CR3): an accessory role for CR3 during virus entry?
H Stoiber, I Frank, M Spruth, et al.
Animal : an International Journal of Animal Bioscience
|
August 11, 2022
Review: Bioavailability of trace elements in farm animals: definition and practical considerations for improved assessment of efficacy and safety
D Brugger, B Wagner, W M Windisch, et al.
Neuro-Degenerative Diseases
|
July 17, 2012
Elevated levels of soluble total and hyperphosphorylated tau result in early behavioral deficits and distinct changes in brain pathology in a new tau transgenic mouse model
S Flunkert, M Hierzer, T Löffler, et al.
Journal of Neural Transmission. Supplementum
|
August 29, 2000
Oral Cerebrolysin enhances brain alpha activity and improves cognitive performance in elderly control subjects
X A Alvarez, V R Lombardi, L Corzo, et al.
Drugs of Today (Barcelona, Spain : 1998)
|
July 16, 2003
Pharmacological treatment of Alzheimer disease: from psychotropic drugs and cholinesterase inhibitors to pharmacogenomics
R Cacabelos, A Alvarez, V Lombardi, et al.
Page
of 9